Spiral Therapeutics Completes $8.25M Financing and Initiates Phase 2 Trial in Ménière's Disease

/PRNewswire/ -- Spiral Therapeutics, Inc. ("Spiral"), a clinical-stage company focused on delivering therapies for inner ear disorders, today announced that...

Related Keywords

Australia ,United States ,Jafri Kuthubutheen ,Division Of Surgery ,Prnewswire Spiral Therapeutics Inc ,Humboldt Fund ,National Institute Of Deafness ,Spiral Therapeutics Inc ,University Of Western Australia ,Savoir Capital ,Catalio Capital Management ,National Institute ,Clinical Associate Professor ,Medical School ,Western Australia ,Principal Investigator ,Charles Limb ,Chief Medical Officer ,Hugo Peris ,Chief Executive Officer ,Spiral Therapeutics ,Nc ,